These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

367 related articles for article (PubMed ID: 15970545)

  • 1. T cell immunity in patients with malignant glioma: recent progress in dendritic cell-based immunotherapeutic approaches.
    Akasaki Y; Black KL; Yu JS
    Front Biosci; 2005 Sep; 10():2908-21. PubMed ID: 15970545
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dendritic cell-based immunotherapy for malignant gliomas.
    Akasaki Y; Black KL; Yu JS
    Expert Rev Neurother; 2005 Jul; 5(4):497-508. PubMed ID: 16026233
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dendritic cell immunotherapy for malignant gliomas.
    Luptrawan A; Liu G; Yu JS
    Rev Recent Clin Trials; 2008 Jan; 3(1):10-21. PubMed ID: 18474011
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dendritic cell vaccines and immunity in glioma patients.
    Wheeler CJ; Black KL
    Front Biosci; 2005 Sep; 10():2861-81. PubMed ID: 15970541
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exploitation of immune mechanisms in the treatment of central nervous system cancer.
    Pollack IF; Okada H; Chambers WH
    Semin Pediatr Neurol; 2000 Jun; 7(2):131-43. PubMed ID: 10914414
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glioma immunology and immunotherapy.
    Parney IF; Hao C; Petruk KC
    Neurosurgery; 2000 Apr; 46(4):778-91; discussion 791-2. PubMed ID: 10764250
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cross-talk between T Cells and Hematopoietic Stem Cells during Adoptive Cellular Therapy for Malignant Glioma.
    Wildes TJ; Grippin A; Dyson KA; Wummer BM; Damiani DJ; Abraham RS; Flores CT; Mitchell DA
    Clin Cancer Res; 2018 Aug; 24(16):3955-3966. PubMed ID: 29712687
    [No Abstract]   [Full Text] [Related]  

  • 8. Immunotherapeutic approaches for glioma.
    Okada H; Kohanbash G; Zhu X; Kastenhuber ER; Hoji A; Ueda R; Fujita M
    Crit Rev Immunol; 2009; 29(1):1-42. PubMed ID: 19348609
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dendritic-cell- and peptide-based vaccination strategies for glioma.
    Yamanaka R
    Neurosurg Rev; 2009 Jul; 32(3):265-73; discussion 273. PubMed ID: 19214609
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cellular immunotherapy for malignant gliomas.
    Lin Y; Okada H
    Expert Opin Biol Ther; 2016 Oct; 16(10):1265-75. PubMed ID: 27434205
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cellular immunity and immunotherapy of brain tumors.
    Prins RM; Liau LM
    Front Biosci; 2004 Sep; 9():3124-36. PubMed ID: 15353342
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cell- and peptide-based immunotherapeutic approaches for glioma.
    Yamanaka R
    Trends Mol Med; 2008 May; 14(5):228-35. PubMed ID: 18403264
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recent progress in immunotherapy for malignant glioma: treatment strategies and results from clinical trials.
    Ehtesham M; Black KL; Yu JS
    Cancer Control; 2004; 11(3):192-207. PubMed ID: 15153843
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effective immunotherapy against murine gliomas using type 1 polarizing dendritic cells--significant roles of CXCL10.
    Fujita M; Zhu X; Ueda R; Sasaki K; Kohanbash G; Kastenhuber ER; McDonald HA; Gibson GA; Watkins SC; Muthuswamy R; Kalinski P; Okada H
    Cancer Res; 2009 Feb; 69(4):1587-95. PubMed ID: 19190335
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dendritic cell-based immunotherapy of malignant gliomas.
    Parajuli P; Sloan AE
    Cancer Invest; 2004; 22(3):405-16. PubMed ID: 15493362
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dendritic cell based vaccination strategy: an evolving paradigm.
    Filley AC; Dey M
    J Neurooncol; 2017 Jun; 133(2):223-235. PubMed ID: 28434112
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunotherapy approaches in the treatment of malignant brain tumors.
    Dunn-Pirio AM; Vlahovic G
    Cancer; 2017 Mar; 123(5):734-750. PubMed ID: 27875627
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunotherapy of diffuse gliomas: biological background, current status and future developments.
    Grauer OM; Wesseling P; Adema GJ
    Brain Pathol; 2009 Oct; 19(4):674-93. PubMed ID: 19744040
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dendritic cell vaccines.
    Yamanaka R; Kajiwara K
    Adv Exp Med Biol; 2012; 746():187-200. PubMed ID: 22639169
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Potential of Cellular- and Viral-Based Immunotherapies for Malignant Glioma-Dendritic Cell Vaccines, Adoptive Cell Transfer, and Oncolytic Viruses.
    Maxwell R; Luksik AS; Garzon-Muvdi T; Lim M
    Curr Neurol Neurosci Rep; 2017 Jun; 17(6):50. PubMed ID: 28488122
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.